ArticleMolecular medicine reports2019

HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain.

Qingfu Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.